These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7940560)

  • 41. Influence of renal impairment, chemical form, and serum protein binding on intravenous and oral aluminum kinetics in the rabbit.
    Yokel RA; McNamara PJ
    Toxicol Appl Pharmacol; 1988 Aug; 95(1):32-43. PubMed ID: 3413794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water.
    Willhite CC; Ball GL; McLellan CJ
    Crit Rev Toxicol; 2012 May; 42(5):358-442. PubMed ID: 22512666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pharmacokinetics and nephrotoxicity of aluminum in rats of various ages].
    Bräunlich H; Gwiasda H; Gwiasda J; Winnefeld K
    Pharmazie; 1988 Sep; 43(9):634-7. PubMed ID: 3244734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Active oxygen species formation in synaptosomes exposed to an aluminum chelator.
    Bondy SC; Tseng H; Orvig C
    Neurotoxicol Teratol; 1998; 20(3):317-20. PubMed ID: 9638689
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of chelation therapy to remove aluminium intoxication.
    Fulgenzi A; De Giuseppe R; Bamonti F; Vietti D; Ferrero ME
    J Inorg Biochem; 2015 Nov; 152():214-8. PubMed ID: 26404567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of iron overload on the metabolism and urinary recovery of 3-hydroxypyridin-4-one chelating agents in the rat.
    Choudhury R; Singh S
    Drug Metab Dispos; 1995 Mar; 23(3):314-20. PubMed ID: 7628295
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subcellular distribution of desferrioxamine and hydroxypyridin-4-one chelators in K562 cells affects chelation of intracellular iron pools.
    Hoyes KP; Porter JB
    Br J Haematol; 1993 Oct; 85(2):393-400. PubMed ID: 8280612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro and in vivo evaluation of potential aluminum chelators.
    Graff L; Muller G; Burnel D
    Vet Hum Toxicol; 1995 Oct; 37(5):455-61. PubMed ID: 8592836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bioavailability and intestinal absorption of aluminum in rats: effects of aluminum compounds and some dietary constituents.
    Cunat L; Lanhers MC; Joyeux M; Burnel D
    Biol Trace Elem Res; 2000 Jul; 76(1):31-55. PubMed ID: 10999429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolism and pharmacokinetics of 1-(2'-hydroxy-ethyl)- and 1-(3'-hydroxypropyl)-2-ethyl-3-hydroxypyridin-4-ones in the rat.
    Singh S; Choudhury R; Epemolu RO; Hider RC
    Eur J Drug Metab Pharmacokinet; 1996; 21(1):33-41. PubMed ID: 8839676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of some dietary constituents on aluminum absorption and retention in rats.
    Domingo JL; Gomez M; Llobet JM; Corbella J
    Kidney Int; 1991 Apr; 39(4):598-601. PubMed ID: 2051716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Accumulation, elimination, and effects of parenteral exposure to aluminum in newborn and adult rats.
    Veiga M; Bohrer D; Banderó CR; Oliveira SM; do Nascimento PC; Mattiazzi P; Mello CF; Lenz QF; Oliveira MS
    J Inorg Biochem; 2013 Nov; 128():215-20. PubMed ID: 23916521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of two isomeric beta-d-glucosiduronic acids derived from 1,2-diethyl-3-hydroxypyridin-4-one (CP94) in rat liver homogenate incubates.
    Liu DY; Liu ZD; Piyamongkol S; Lu SL; Hider RC
    J Pharm Pharmacol; 2002 Jul; 54(7):951-7. PubMed ID: 12162714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of desferrioxamine on tissue aluminum concentration and bone histology in aluminum-loaded rats with renal failure.
    Verbeelen D; Smeyers-Verbeke J; van Hooff I; de Roy G
    J Trace Elem Electrolytes Health Dis; 1988 Jun; 2(2):67-72. PubMed ID: 2980801
    [TBL] [Abstract][Full Text] [Related]  

  • 55. N-Arylamine derivatives of 3-hydroxy-4-pyridinones: solution studies and bioevaluation in view of Al-detoxification roles.
    Santos MA; Gil M; Marques S; Gano L; Chaves S
    Anal Bioanal Chem; 2005 Jan; 381(2):413-9. PubMed ID: 15455189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of oral aluminum and aluminum citrate on blood level and short-term tissue distribution of aluminum in the rat.
    Deng Z; Coudray C; Gouzoux L; Mazur A; Rayssiguier Y; Pépin D
    Biol Trace Elem Res; 1998 Aug; 63(2):139-47. PubMed ID: 9823440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chelation of aluminium by combining DFO and L1 in rats.
    Blanusa M; Prester L; Varnai VM; Pavlović D; Kostial K; Jones MM; Singh PK
    Toxicology; 2000 Jul; 147(3):151-6. PubMed ID: 10924797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aluminum bioavailability and disposition in adult and immature rabbits.
    Yokel RA; McNamara PJ
    Toxicol Appl Pharmacol; 1985 Feb; 77(2):344-52. PubMed ID: 3975904
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The efficacy of deferiprone on tissues aluminum removal and copper, zinc, manganese level in rabbits.
    Liu P; Yao YN; Wu SD; Dong HJ; Feng GC; Yuan XY
    J Inorg Biochem; 2005 Aug; 99(8):1733-7. PubMed ID: 16045992
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Zinc status does not affect aluminum deposition in tissues of rats.
    McNall AD; Fosmire GJ
    Biol Trace Elem Res; 1996; 53(1-3):7-18. PubMed ID: 8862733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.